{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:18:00Z","timestamp":1790371080229,"version":"4.1.0"},"reference-count":27,"publisher":"Baskent University","issue":"Suppl 5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Transplant"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.6002\/ect.pedsymp2024.o5","type":"journal-issue","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T05:04:51Z","timestamp":1730351091000},"source":"Crossref","is-referenced-by-count":2,"title":[],"prefix":"10.6002","volume":"22","member":"4021","reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. LaRosa C, Baluarte HJ, Meyers KE. Outcomes in pediatric solid-organ transplantation. Pediatr Transplant. 2011;15(2):128-141. doi:10.1111\/j.1399-3046.2010.01434.x","DOI":"10.1111\/j.1399-3046.2010.01434.x"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2. Vincenzi R, Fonseca EA, Roda KMO, Chapchap P, Neto JS. Current practice in immunosuppression in pediatric liver transplantation. Curr Pharm Des. 2020;26(28):3402-3405. doi:10.2174\/1381612826666200614181526","DOI":"10.2174\/1381612826666200614181526"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3. Arasaratnam RJ, Tzannou I, Gray T, et al. Dynamics of virus-specific T cell immunity in pediatric liver transplant recipients. Am J Transplant. 2018;18(9):2238-2249. doi:10.1111\/ajt.14967","DOI":"10.1111\/ajt.14967"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Rubinstein J, Toner K, Gross T, Wistinghausen B. Diagnosis and management of post-transplant lymphoproliferative disease following solid organ transplantation in children, adolescents, and young adults. Best Pract Res Clin Haematol. 2023;36(1):101446. doi:10.1016\/j.beha.2023.101446","DOI":"10.1016\/j.beha.2023.101446"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Ozcay F. Lymphoproliferative disease after pediatric liver transplant. Exp Clin Transplant. 2017;15(Suppl 2):79-81. doi:10.6002\/ect.TOND16.L22","DOI":"10.6002\/ect.TOND16.L22"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Parrish A, Fenchel M, Storch GA, et al. Epstein-Barr viral loads do not predict post-transplant lymphoproliferative disorder in pediatric lung transplant recipients: a multicenter prospective cohort study. Pediatr Transplant. 2017;21(6). doi:10.1111\/petr.13011","DOI":"10.1111\/petr.13011"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7. Elidemir O, Kancherla BS, Schecter MG, et al. Post-transplant lymphoproliferative disease in pediatric lung transplant recipients: recent advances in monitoring. Pediatr Transplant. 2009;13(5):606-610. doi:10.1111\/j.1399-3046.2008.01085.x","DOI":"10.1111\/j.1399-3046.2008.01085.x"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8. Quintini C, Kato T, Gaynor JJ, et al. Analysis of risk factors for the development of posttransplant lymphoproliferative disorder among 119 children who received primary intestinal transplants at a single center. Transplant Proc. 2006;38(6):1755-1758. doi:10.1016\/j.transproceed.2006.05.039","DOI":"10.1016\/j.transproceed.2006.05.039"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9. Manlhiot C, Pollock-Barziv SM, Holmes C, et al. Post-transplant lymphoproliferative disorder in pediatric heart transplant recipients. J Heart Lung Transplant. 2010;29(6):648-657. doi:10.1016\/j.healun.2010.01.013","DOI":"10.1016\/j.healun.2010.01.013"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"10. Narkewicz MR, Green M, Dunn S, et al. Decreasing incidence of symptomatic Epstein-Barr virus disease and posttransplant lymphoproliferative disorder in pediatric liver transplant recipients: report of the studies of pediatric liver transplantation experience. Liver Transpl. 2013;19(7):730-740. doi:10.1002\/lt.23659","DOI":"10.1002\/lt.23659"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Dharnidharka VR, Ho PL, Stablein DM, Harmon WE, Tejani AH. Mycophenolate, tacrolimus and post-transplant lymphoproliferative disorder: a report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant. 2002;6(5):396-399. doi:10.1034\/j.1399-3046.2002.00021.x","DOI":"10.1034\/j.1399-3046.2002.00021.x"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12. Heo JS, Park JW, Lee KW, et al. Posttransplantation lymphoproliferative disorder in pediatric liver transplantation. Transplant Proc. 2004;36(8):2307-2308. doi:10.1016\/j.transproceed.2004.08.138","DOI":"10.1016\/j.transproceed.2004.08.138"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13. Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 2011;117(19):5019-5032. doi:10.1182\/blood-2011-01-293050","DOI":"10.1182\/blood-2011-01-293050"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14. Taj MM, Maecker-Kolhoff B, Ling R, et al. Primary post-transplant lymphoproliferative disorder of the central nervous system: characteristics, management and outcome in 25 paediatric patients. Br J Haematol. 2021;193(6):1178-1184. doi:10.1111\/bjh.17398","DOI":"10.1111\/bjh.17398"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. L'Huillier AG, Dipchand AI, Ng VL, et al. Posttransplant lymphoproliferative disorder in pediatric patients: characteristics of disease in EBV-seropositive recipients. Transplantation. 2019;103(11):e369-e374. doi:10.1097\/TP.0000000000002898","DOI":"10.1097\/TP.0000000000002898"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16. Yang F, Li Y, Braylan R, Hunger SP, Yang LJ. Pediatric T-cell post-transplant lymphoproliferative disorder after solid organ transplantation. Pediatr Blood Cancer. 2008;50(2):415-418. doi:10.1002\/pbc.21072","DOI":"10.1002\/pbc.21072"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17. Jeong HJ, Ahn YH, Park E, et al. Posttransplantation lymphoproliferative disorder after pediatric solid organ transplantation: experiences of 20 years in a single center. Korean J Pediatr. 2017;60(3):86-93. doi:10.3345\/kjp.2017.60.3.86","DOI":"10.3345\/kjp.2017.60.3.86"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Baris Z, Ozcay F, Yilmaz Ozbek O, Haberal N, Sarialioglu F, Haberal M. A single-center experience of post-transplant lymphoproliferative disorder (PTLD) cases after pediatric liver transplantation: incidence, outcomes, and association with food allergy. Turk J Gastroenterol. 2018;29(3):354-360. doi:10.5152\/tjg.2018.17731","DOI":"10.5152\/tjg.2018.17731"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19. Akar Ozkan E, Ozdemir BH, Deniz EE, Tunca MZ, Haberal M. Posttransplant lymphoproliferative disorder after liver and kidney transplant. Exp Clin Transplant. 2014;12(Suppl 1):142-148. doi:10.6002\/ect.25Liver.P30","DOI":"10.6002\/ect.25Liver.P30"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20. Giraldi E, Provenzi M, Conter V, et al. Risk-adapted treatment for severe B-lineage posttransplant lymphoproliferative disease after solid organ transplantation in children. Transplantation. 2016;100(2):437-445. doi:10.1097\/TP.0000000000000845","DOI":"10.1097\/TP.0000000000000845"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Odumade OA, Hogquist KA, Balfour HH, Jr. Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev. 2011;24(1):193-209. doi:10.1128\/CMR.00044-10","DOI":"10.1128\/CMR.00044-10"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. AlDabbagh MA, Gitman MR, Kumar D, Humar A, Rotstein C, Husain S. The role of antiviral prophylaxis for the prevention of Epstein-Barr virus-associated posttransplant lymphoproliferative disease in solid organ transplant recipients: a systematic review. Am J Transplant. 2017;17(3):770-781. doi:10.1111\/ajt.14020","DOI":"10.1111\/ajt.14020"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Reshef R, Vardhanabhuti S, Luskin MR, et al. Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder. Am J Transplant. 2011;11(2):336-347. doi:10.1111\/j.1600-6143.2010.03387.x","DOI":"10.1111\/j.1600-6143.2010.03387.x"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Green M, Michaels MG. Epstein-Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant. 2013;13 Suppl 3:41-54; quiz 54. doi:10.1111\/ajt.12004","DOI":"10.1111\/ajt.12004"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25. Green M, Michaels MG, Katz BZ, et al. CMV-IVIG for prevention of Epstein Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients. Am J Transplant. 2006;6(8):1906-1912. doi:10.1111\/j.1600-6143.2006.01394.x","DOI":"10.1111\/j.1600-6143.2006.01394.x"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Humar A, Hebert D, Davies HD, et al. A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder. Transplantation. 2006;81(6):856-861. doi:10.1097\/01.tp.0000202724.07714.a2","DOI":"10.1097\/01.tp.0000202724.07714.a2"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Green M, Reyes J, Webber S, Rowe D. The role of antiviral and immunoglobulin therapy in the prevention of Epstein-Barr virus infection and post-transplant lymphoproliferative disease following solid organ transplantation. Transpl Infect Dis. 2001;3(2):97-103. doi:10.1034\/j.1399-3062.2001.003002097.x","DOI":"10.1034\/j.1399-3062.2001.003002097.x"}],"container-title":["Experimental and Clinical Transplantation"],"original-title":[],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T07:05:41Z","timestamp":1730358341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ectrx.org\/detail\/supplement\/2024\/22\/10\/5\/35\/0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":27,"journal-issue":{"issue":"Suppl 5","published-print":{"date-parts":[[2024,10]]}},"URL":"https:\/\/doi.org\/10.6002\/ect.pedsymp2024.o5","relation":{},"ISSN":["1304-0855","2146-8427"],"issn-type":[{"value":"1304-0855","type":"print"},{"value":"2146-8427","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]}}}